Pharmacokinetics of O⁶-benzylguanine and its active metabolite 8-oxo-O⁶-benzylguanine in plasma and cerebrospinal fluid after intrathecal administration of O⁶-benzylguanine in the nonhuman primateBERG, S. L; MURRY, D. J; MCCULLY, C. L et al.Clinical cancer research. 1998, Vol 4, Num 11, pp 2891-2894, issn 1078-0432Article

Ifosfamide-induced hyperpigmentationTERESI, M. E; MURRY, D. J; CORNELIUS, A. S et al.Cancer. 1993, Vol 71, Num 9, pp 2873-2875, issn 0008-543XArticle

Comparative clinical pharmacology of cisplatin and carboplatinMURRY, D. J.Pharmacotherapy. 1997, Vol 17, Num 5, pp 140S-145S, issn 0277-0008, 2Conference Paper

Pharmacokinetics of ibuprofen in patients with cystic fibrosisMURRY, D. J; OERMANN, C. M; OU, C.-N et al.Pharmacotherapy. 1999, Vol 19, Num 3, pp 340-345, issn 0277-0008Article

Liver volume as a determinant of drug clearance in children and adolescentsMURRY, D. J; CROM, W. R; REDDICK, W. E et al.Drug metabolism and disposition. 1995, Vol 23, Num 10, pp 1110-1116, issn 0090-9556Article

Pharmacokinetics and acute renal effects of continuously infused carboplatinMURRY, D. J; SANDLUND, J. T; STRICKLIN, L. M et al.Clinical pharmacology and therapeutics. 1993, Vol 54, Num 4, pp 374-380, issn 0009-9236Article

Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer : a phase II study from indiana UniversityKURUP, A; LIN, C.-W; MURRY, D. J et al.Annals of oncology. 2006, Vol 17, Num 1, pp 97-103, issn 0923-7534, 7 p.Article

Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate modelBERG, S. L; REID, J; GODWIN, K et al.Journal of pediatric hematology/oncology. 1999, Vol 21, Num 1, pp 26-30, issn 1077-4114Article

Plasma and cerebrospinal fluid pharmacokinetics of 9-aminocamptothecin (9-AC), irinotecan (CPT-11), and SN-38 in nonhuman primatesBLANEY, S. M; TAKIMOTO, C; MURRY, D. J et al.Cancer chemotherapy and pharmacology. 1998, Vol 41, Num 6, pp 464-468, issn 0344-5704Article

Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primatesSERABE, B. M; MURRY, D. J; DAUSER, R et al.Cancer chemotherapy and pharmacology. 1999, Vol 43, Num 5, pp 415-418, issn 0344-5704Article

Carboplatin pharmacokinetics in young children with brain tumorsTONDA, M. E; HEIDEMAN, R. L; PETROS, W. P et al.Cancer chemotherapy and pharmacology. 1996, Vol 38, Num 5, pp 395-400, issn 0344-5704Article

Formation of platinum-DNA adducts in pediatric patients receiving carboplatinTONDA, M. E; MURRY, D. J; RODMAN, J. H et al.Pharmacotherapy. 1996, Vol 16, Num 4, pp 631-637, issn 0277-0008Article

Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumorsMARINA, N. M; RODMAN, J. H; MURRY, D. J et al.Journal of the National Cancer Institute. 1994, Vol 86, Num 7, pp 544-548, issn 0027-8874Article

Pharmacokinetics and metabolism of oral midazolam in preterm infantsDE WILDT, S. N; KEARNS, G. L; HOP, W. C. J et al.British journal of clinical pharmacology. 2002, Vol 53, Num 4, pp 390-392, issn 0306-5251, 3 p.Article

Pharmacokinetics and metabolism of intravenous midazolam in preterm infantsDE WILDT, S. N; KEARNS, G. L; HOP, W. C. J et al.Clinical pharmacology and therapeutics. 2001, Vol 70, Num 6, pp 525-531, issn 0009-9236Article

Renal function and methotrexate clearance in children with newly diagnosed leukemiaMURRY, D. J; SYNOLD, T. W; CHING-HON PUI et al.Pharmacotherapy. 1995, Vol 15, Num 2, pp 144-149, issn 0277-0008Article